The executive director of ARPharM, the Bulgarina pharma trade group, delivered the "Evolution of Access to Health in Bulgaria over the last decade" presentation at the ISPOR Bulgaria chapter and ISPOR CEE Chapter 11th Adriatic Congress on Pharmacoeconomics and Outcomes Research with Focus on CEE in Sofia.
In the past decade, access to healthcare in Bulgaria undoubtedly has improved. Public funding has doubled but remains significantly lower than the European Union (EU) average. Out-of-pocket payments are quite high. The number of hospital beds, outpatient centers, medical labs and doctors has increased. However, medical care remains unevenly distributed in the country and there is a severe shortage of nurses. Prevention and screening remain at a very low level.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze